Shigeno M - Search Results

1

Involvement of IL-1beta and IL-10 in IFN-alpha-mediated antiviral gene induction in human hepatoma cells.

Ichikawa T, Nakao K, Nakata K, Yamashita M, Hamasaki K, Shigeno M, Abiru S, Ishikawa H, Ishii N, Eguchi K. Ichikawa T, et al. Among authors: shigeno m. Biochem Biophys Res Commun. 2002 Jun 7;294(2):414-22. doi: 10.1016/S0006-291X(02)00502-8. Biochem Biophys Res Commun. 2002. PMID: 12051728

2

Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression.

Takeda Y, Nakao K, Nakata K, Kawakami A, Ida H, Ichikawa T, Shigeno M, Kajiya Y, Hamasaki K, Kato Y, Eguchi K. Takeda Y, et al. Among authors: shigeno m. Jpn J Cancer Res. 2001 Sep;92(9):918-25. doi: 10.1111/j.1349-7006.2001.tb01181.x. Jpn J Cancer Res. 2001. PMID: 11572758 Free PMC article.

3

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells.

Abiru S, Nakao K, Ichikawa T, Migita K, Shigeno M, Sakamoto M, Ishikawa H, Hamasaki K, Nakata K, Eguchi K. Abiru S, et al. Among authors: shigeno m. Hepatology. 2002 May;35(5):1117-24. doi: 10.1053/jhep.2002.32676. Hepatology. 2002. PMID: 11981761

4

Interferon-alpha sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-kappa B inactivation.

Shigeno M, Nakao K, Ichikawa T, Suzuki K, Kawakami A, Abiru S, Miyazoe S, Nakagawa Y, Ishikawa H, Hamasaki K, Nakata K, Ishii N, Eguchi K. Shigeno M, et al. Oncogene. 2003 Mar 20;22(11):1653-62. doi: 10.1038/sj.onc.1206139. Oncogene. 2003. PMID: 12642868

5

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection.

Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, Abiru S, Nakagawa Y, Shigeno M, Miyazoe S, Ichikawa T, Ishikawa H, Nakao K, Eguchi K. Ohata K, et al. Among authors: shigeno m. Cancer. 2003 Jun 15;97(12):3036-43. doi: 10.1002/cncr.11427. Cancer. 2003. PMID: 12784339 Free article.

6

[A case of extrahepatic portal vein stenosis with portal hypertension, coexisting with arterioportal shunt].

Saeki A, Matsumoto K, Yanagi K, Nishimura D, Hamada H, Ohata K, Abiru S, Shigeno M, Nakagawa Y, Ishikawa H, Hamasaki K, Sakamoto I, Nakao K, Toriyama K, Eguchi K. Saeki A, et al. Among authors: shigeno m. Nihon Shokakibyo Gakkai Zasshi. 2003 Jun;100(6):697-701. Nihon Shokakibyo Gakkai Zasshi. 2003. PMID: 12833865 Japanese. No abstract available.

7

Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells.

Ohata K, Ichikawa T, Nakao K, Shigeno M, Nishimura D, Ishikawa H, Hamasaki K, Eguchi K. Ohata K, et al. Among authors: shigeno m. FEBS Lett. 2003 Oct 23;553(3):304-8. doi: 10.1016/s0014-5793(03)01034-2. FEBS Lett. 2003. PMID: 14572641 Free article.

8

Liver Function in Older Patients With Unresectable Hepatocellular Carcinoma After Administration of Lenvatinib.

Sasaki R, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, Hidaka M, Eguchi S, Matsuo S, Matsuzaki T, Hashimoto S, Ohba K, Kugiyama Y, Yatsuhashi H, Shibata H, Motoyoshi Y, Shigeno M, Iwatsu S, Kato Y, Kinoshita N, Nakao K. Sasaki R, et al. Among authors: shigeno m. Anticancer Res. 2021 Apr;41(4):2025-2032. doi: 10.21873/anticanres.14970. Anticancer Res. 2021. PMID: 33813409

9

Evaluating the Role of Hepatobiliary Phase of Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Predicting Treatment Impact of Lenvatinib and Atezolizumab plus Bevacizumab on Unresectable Hepatocellular Carcinoma.

Sasaki R, Nagata K, Fukushima M, Haraguchi M, Miuma S, Miyaaki H, Soyama A, Hidaka M, Eguchi S, Shigeno M, Yamashima M, Yamamichi S, Ichikawa T, Kugiyama Y, Yatsuhashi H, Nakao K. Sasaki R, et al. Among authors: shigeno m. Cancers (Basel). 2022 Feb 6;14(3):827. doi: 10.3390/cancers14030827. Cancers (Basel). 2022. PMID: 35159095 Free PMC article.

10

Miuma S, Miyaaki H, Ichikawa T, Matsuzaki T, Goto T, Kamo Y, Shigeno M, Hino N, Ario K, Yanagi K, Tsutsumi T, Fukushima N, Nakashiki S, Yamasaki K, Hamasaki K, Shibata H, Arima K, Yamamichi S, Yamashima M, Takahashi K, Nakao Y, Fukushima M, Haraguchi M, Sasaki R, Ozawa E, Taura N, Nakao K. Miuma S, et al. Among authors: shigeno m. J Med Virol. 2024 Mar;96(3):e29432. doi: 10.1002/jmv.29432. J Med Virol. 2024. PMID: 38509793

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters